ethylisopropylamiloride has been researched along with Ischemic Attack, Transient in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hwang, IK | 1 |
Yoo, KY | 1 |
An, SJ | 1 |
Li, H | 1 |
Lee, CH | 1 |
Choi, JH | 1 |
Lee, JY | 1 |
Lee, BH | 1 |
Kim, YM | 1 |
Kwon, YG | 1 |
Won, MH | 1 |
1 other study available for ethylisopropylamiloride and Ischemic Attack, Transient
Article | Year |
---|---|
Late expression of Na+/H+ exchanger 1 (NHE1) and neuroprotective effects of NHE inhibitor in the gerbil hippocampal CA1 region induced by transient ischemia.
Topics: Amiloride; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gen | 2008 |